17th Annual Needham Healthcare Conference (Live)
03/27/18 at 4:00 p.m. ET
Cowen and Company 38th Annual Health Care Conference (Replay)
03/12/18 at 2:10 p.m. ET
On March 14, 2016, Nuvectra Corporation completed its spin-off from Greatbatch, Inc. into an independent, publicly-traded neurostimulation medical device company. The company is headquartered in Plano, Texas, with additional locations in Denver, Ann Arbor, and Minneapolis.
Nuvectra currently trades on the NASDAQ Global Market (NASDAQ) under the ticker symbol "NVTR."
Data provided by Nasdaq. Minimum 15 minutes delayed.
March 06, 2018
Nuvectra™ Reports Fourth Quarter and Full Year 2017 Financial Results
Record Quarterly Algovita® Revenue of $10.4 Million PLANO, Texas, March 06, 2018 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, today announced financial results for the fourth quarter and full year ended December 31, 2017. Recent Company Highlights Reported record consolidated revenues of $12.0 million for the fourth quarter 2017 and $31.8 million for the full year 2017. Achieved the 1,000th Algovita® SCS System implantation in U
February 27, 2018
Nuvectra to Present at Two Upcoming Investor Conferences
PLANO, Texas, Feb. 27, 2018 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, announced today that Scott Drees, Chief Executive Officer, and Walter Berger, Chief Operating Officer & Chief Financial Officer, are scheduled to present at two upcoming investor conferences. Event: Cowen and Company 38th Annual Health Care Conference Date: Monday, March 12, 2018 Time: 2:10 p.m. ET
The Ruth Group